Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol (Q35182162)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol |
scientific article |
Statements
1 reference
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol (English)
1 reference
K A Blum
1 reference
A S Ruppert
1 reference
J A Woyach
1 reference
J A Jones
1 reference
L Andritsos
1 reference
J M Flynn
1 reference
B Rovin
1 reference
M Villalona-Calero
1 reference
J Ji
1 reference
M Phelps
1 reference
A J Johnson
1 reference
M R Grever
1 reference
J C Byrd
1 reference
1 reference
1 reference
Identifiers
1 reference